Pharmalot By Ed Silverman McKinsey agrees to $573 million settlement over advice given Purdue and other opioid makers
Pharmalot By Ed Silverman ‘Use that money wisely’: Coalition urges governments to spend opioid settlement funds on evidence-based efforts
Exclusive By Shraddha Chakradhar and Casey Ross The history of OxyContin, told through unsealed Purdue documents
Special Report By Andrew Joseph The surgeon general and his brother: A family’s painful reckoning with addiction
Pharmalot By Ed Silverman To maintain opioid sales, Purdue was advised to pay rebates to health insurers for each overdose
Health By Emily Mullin Patient advocates and scientists launch push to lift ban on ‘three-parent IVF’
Pharma By Madlen Davies, Ivan Ruiz, Jill Langlois, and Rosa Furneaux — The Bureau of Investigative Journalism ‘Held to ransom’: Pfizer plays hardball in Covid-19 vaccine negotiations with Latin American countries
Pharmalot By Ed Silverman Bristol Myers and Sanofi ordered to pay $834 million to Hawaii for withholding Plavix label
Pharmalot By Ed Silverman Drug maker agrees to plead guilty to hiding and destroying records before FDA inspection
Pharmalot By Ed Silverman To the delight of generic drug makers, federal appeals court tosses controversial ‘skinny labeling’ decision
Pharmalot By Ed Silverman Former Merck employee arrested for stealing trade secrets on cancer research
First Opinion By Samuel Tarry and Davis Walsh Keep Covid-19 vaccination decisions out of the courtroom
Pharmalot By Ed Silverman Generic drug makers fear a ‘skinny labeling’ court ruling will pose a huge threat
First Opinion By Gregory Jasani and James Maloy Emergency department physicians should have the right to due process protection. Many don’t
Pharmalot By Ed Silverman A historian was cited to support making Purdue a public benefit company. He actually thinks it’s a bad idea
First Opinion By Cecile Riboud In biopharma mergers and acquisitions, managing regulatory compliance early protects return on investment
Pharmalot By Ed Silverman Supreme Court upholds controversial Arkansas law that regulates pharmacy benefit managers
Pharmalot By Ed Silverman Lawmakers urge Justice Department to revise $8.3 billion settlement with Purdue
Pharmalot By Ed Silverman Abbott sues a former executive for allegedly planning to take Covid-19 diagnostics secrets to a rival
Pharmalot By Ed Silverman Purdue will plead guilty to federal charges, reaches $8.3 billion deal over opioid crisis
Pharmalot By Ed Silverman Pharma contributed to attorneys general who want to repeal the Affordable Care Act
Pharmalot By Ed Silverman State treasurers urge Cardinal Health shareholders to reject CEO bonus over opioid crisis
First Opinion By Joy Sturm Navigating the new ‘buy American’ drug landscape: opportunities for some, pitfalls for others
Pharmalot By Ed Silverman AstraZeneca loses first-of-its-kind lawsuit filed by Dutch insurer over patent maneuver
Pharmalot By Ed Silverman Supreme Court to review contentious state law governing pharmacy benefit managers
Pharmalot By Ed Silverman Appeals court hands FTC a setback that invalidates its ability to claw back millions from AbbVie